Nanomedicine News

RSS

Essen, Nycomed to Develop New Small Molecule Ion Channel Modulators

Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services – and Nycomed – a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.

22 Jun 2010

Nanoviricides Reports Significant Efficacy of Anti-Dengue Drug Candidates in Initial Studies

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley (UC Berkeley).

From NanoViricides, Inc 21 Jun 2010

NanoBioMagnetics Awarded NSF Phase I SBIR Grant

Officials at NanoBioMagnetics announced today that the company has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Science Foundation to study the effectiveness of magnetically ve...

18 Jun 2010

Savara to Receive ETF Grant to Develop New NanoCluster-Based Therapies

Savara, Inc., an inhalation drug delivery company, today announced that it has been chosen by the state of Texas as the recipient of a commercialization award funded through the Texas Emerging Technology Fund (ETF)....

16 Jun 2010

Researchers Explain Beading Mechanism of Saliva and Other Complex Fluids

Researchers at Rice University, Purdue University and the Massachusetts Institute of Technology have solved a long-standing mystery about why some fluids containing polymers -- including saliva -- form beads when th...

15 Jun 2010

Access Pharma to Conduct Cobalamin siRNA Program at CNSI Symposium

ACCESS PHARMACEUTICALS, INC. (OTC:ACCP) (BULLETIN BOARD: ACCP) , a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Senior VP of R&D, David Nowotnik, Ph.D., w...

From Abeona Therapeutics Inc. 15 Jun 2010

Researchers Use Novel Gene Therapy to Prevent Blindness Caused by Retinitis Pigmentosa

Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease.

14 Jun 2010

Bacterial Study May Help Develop New and Effective Drugs for Infections

For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane.

14 Jun 2010

Ensysce Secures Funds to Develop Single Walled Carbon Nanotube for siRNA Delivery

Ensysce Biosciences Inc. announced today they have received funding from the State of Texas Emerging Technology Fund. Funding of up to $1.5 million has been approved for the development of single walled carbon nanotube (SWCNT) therapeutics for the delivery of siRNA.

11 Jun 2010

Silk Microchip for Rapid Medical Testing

Silk could provide a sophisticated new way of monitoring health, Peter Domachuk, a physicist from the University of Sydney, has found. He and his colleagues have created microchips using silk fibres. In the lab they've demonstrated that these microchips can measure oxygen using haemoglobin embedded in the silk.

10 Jun 2010